98%
921
2 minutes
20
The clinical application of randomly patterned skin flaps is often limited by their length-to-width ratio, which can negatively impact their viability. This study aims to investigate the effect of ginsenoside Rb1 on the survival of random skin flaps and explores the underlying mechanisms using metabonomic approaches. Sprague-Dawley rats were assigned to a control group, an ischemia-reperfusion (I/R) group, and a ginsenoside Rb1 treatment group. The serum and middle flap tissue of the rats were collected for H-NMR spectroscopy detection and computer pattern recognition analysis. Ten days post-surgery, the survival rate of dorsal flaps in Rb1 group (61.06 ± 3.71) % was significantly higher than in I/R group (50.46 ± 1.41)%. Analyses of H-NMR spectrum 24 h post-surgery demonstrated increased lipid content in the serum of I/R group. In contrast, serum samples from the Rb1 group exhibited significantly higher levels of glutamate, creatine and fumarate, while lactate, choline/phosphocholine, N-acetylglycoprotein and allantoin were decreased. The contents of ATP/ADP/AMP of glutamine, citrate, tauric acid, and fumarate in flap tissue were increased while those of lactate, acetate and acetoacetate were significantly decreased. These findings suggest that ginsenoside Rb1 may enhance the survival of random skin flaps, potentially providing protective benefits in clinical applications.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11876603 | PMC |
http://dx.doi.org/10.1038/s41598-025-91798-z | DOI Listing |
Mater Today Bio
October 2025
Department of Anesthesiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China.
Inflammatory diseases (IDs), characterized by chronic inflammation, are linked to conditions such as bacterial and viral infections, arthritis, and neurodegenerative disorders. Current treatments offer only temporary relief, highlighting the need for more effective therapies. Ginsenoside Rb1 (Rb1), with potent anti-inflammatory and antioxidant properties, can self-assemble into nanoparticles.
View Article and Find Full Text PDFColloids Surf B Biointerfaces
August 2025
Jilin Ginseng Academy, Innovation and Entrepreneurship College, Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, PR China. Electronic address:
This study synthesized bioactive carbon nanodots (Rb1-CDs) from ginsenoside Rb1 via hydrothermal processing. The Rb1-CDs demonstrated a uniform size distribution (5.3 ± 1.
View Article and Find Full Text PDFChin Med
August 2025
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Background: The gut microbiota plays a critical role in the biotransformation of saponins. However, current research predominantly focuses on metabolism by single microbial species, with limited investigation into inter-species differences or inter-individual variability in saponin biotransformation, especially by the culture of mixed gut microbiota. This study aims to elucidate the species-specific differences and inter-individual variability in gut microbiota-mediated saponin biotransformation through multidimensional analysis.
View Article and Find Full Text PDFJ Ginseng Res
September 2025
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Background: Ginsenoside Rb1 is a prominent bioactive component in traditional Chinese medicine.
Purpose: This study investigated the molecular mechanisms underlying the protective effects of Ginsenoside Rb1 on endothelium during ischemia-reperfusion (I/R) injury.
Materials And Methods: To enrich for marker genes and investigate the differential expression of DUSP1 and NDUFS4 in coronary artery disease, single-cell transcriptome sequencing was utilized.
J Ginseng Res
September 2025
The Key Laboratory of Fujian Province Universities on Ion Channel and Signal Transduction in Cardiovascular Diseases, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.
Background: Myocardial hypertrophy is a crucial pathological change that occurs during post-anthracycline treatment cardiomyopathy. The effects of ginsenoside Rb1 (Rb1) on anthracycline-induced hypertrophy remain unclear. This study aimed to explore the antihypertrophic effect of Rb1 on post-doxorubicin (DOX) treatment myocardial hypertrophy and underlying mechanism.
View Article and Find Full Text PDF